Related references
Note: Only part of the references are listed.Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions
Asaf Yanir et al.
FRONTIERS IN PEDIATRICS (2022)
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
Chenchen Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse
Viviane Gournay et al.
BLOOD (2022)
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi et al.
BLOOD ADVANCES (2021)
Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease
Gerard Socie et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Methotrexate and its mechanisms of action in inflammatory arthritis
Bruce N. Cronstein et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation
Lia Minculescu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors
Brian Kornblit et al.
BLOOD (2020)
Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources
Reem Elfeky et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)
Mahasweta Gooptu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Brenda M. Sandmaier et al.
LANCET HAEMATOLOGY (2019)
Intra-lineage Plasticity and Functional Reprogramming Maintain Natural Killer Cell Repertoire Diversity
Aline Pfefferle et al.
CELL REPORTS (2019)
Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation
Edmund K. Waller et al.
BLOOD ADVANCES (2019)
Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease
Maria V. Soares et al.
FRONTIERS IN IMMUNOLOGY (2019)
Early Reconstitution of NK and gamma delta T Cells and Its Implication for the Design of Post-Transplant Immunotherapy
Moniek A. de Witte et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
Fangjie Wang et al.
NATURE COMMUNICATIONS (2018)
SCANPY: large-scale single-cell gene expression data analysis
F. Alexander Wolf et al.
GENOME BIOLOGY (2018)
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
Antonio Russo et al.
BLOOD (2018)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention
F. Khimani et al.
BONE MARROW TRANSPLANTATION (2017)
Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation
Lia Minculescu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease
Mathias Lutz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Johan Torlen et al.
HAEMATOLOGICA (2016)
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation
Kristen N. Pollizzi et al.
NATURE IMMUNOLOGY (2016)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Johan Torlen et al.
HAEMATOLOGICA (2016)
Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
Justyna Ogonek et al.
FRONTIERS IN IMMUNOLOGY (2016)
Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing
Conor J. Kearney et al.
ONCOIMMUNOLOGY (2016)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome
Caroline Pical-Izard et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Coordinated Expression of DNAM-1 and LFA-1 in Educated NK Cells
Monika Enqvist et al.
JOURNAL OF IMMUNOLOGY (2015)
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Corey Cutler et al.
BLOOD (2014)
Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis
S. Mielke et al.
BONE MARROW TRANSPLANTATION (2014)
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Raymond P. Donnelly et al.
JOURNAL OF IMMUNOLOGY (2014)
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Antoine Marais et al.
NATURE IMMUNOLOGY (2014)
Immune reconstitution after hematopoietic cell transplantation
Mark Bosch et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD
S. Thiant et al.
BONE MARROW TRANSPLANTATION (2011)
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Olle Ringden et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Use of sirolimus in solid organ transplantation
Joshua J. Augustine et al.
DRUGS (2007)
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
BN Savani et al.
BLOOD (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
D Pende et al.
BLOOD (2005)
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
C Cutler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
JH Antin et al.
BLOOD (2003)
Share Paper
